---
$id: https://graph.org.ai/products/commodity/51283711
$type: Product
source: UNSPSC
code: "51283711"
title: "Loracarbef"
class: "51283700"
classTitle: "Second generation cephalosporins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Loracarbef

**UNSPSC Code**: 51283711
**Class**: [Second generation cephalosporins](Second generation cephalosporins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cephalosporin antibiotic with the molecular formula C16H16ClN3O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3X11EVM5SU, chemically known as 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6r-(6alpha,7beta(r*)))- but generally known as loracarbef, which bears US NIH Compound Identifier 3956. European Medicines Agency schedules Loracarbef in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08578MIG. World Health Organization schedules loracarbef in its Anatomical Therapeutic Chemical (ATC) Classification. LORACARBEF is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule loracarbef under HS 29419000 and SITC 54139. As of Q4 2014, LORACARBEF remains the US FDA Preferred Term for this commodity. Loracarbef bears US NLM identifiers UMLS ID C0721422 and NCI Concept Code C47588. SMILES: CLC1=C(N2C(C(NC(=O)C(N)C3CCCCC3)C2=O)CC1)C(=O)O.

